Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer-Reference-Cited by-同舟云学术

Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer

Published:2021-05-10 Issue:3 Volume:275 Page:467-476
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

van der Wilk Berend J.,Eyck Ben M.,Hofstetter Wayne L.,Ajani Jaffer A.,Piessen Guillaume,Castoro Carlo,Alfieri Rita,Kim Jong H.,Kim Sung-Bae,Furlong Heidi,Walsh Thomas N.,Nieboer Daan,Wijnhoven Bas P. L.,Lagarde Sjoerd M.,Lanschot J. Jan B. van

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference32 articles.

1. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma;Walsh;N Engl J Med,1996

2. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

3. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial;Yang;J Clin Oncol,2018

4. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

5. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial;Al-Batran;Lancet,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials;Radiotherapy and Oncology;2024-11

2. Needs, preferences, and patient participation for a randomized controlled trial on postneoadjuvant complete tumor response: A qualitative study of patients with esophageal cancer;Supportive Care in Cancer;2024-09-11

3. Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis;Clinical and Translational Radiation Oncology;2024-09

4. Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study;Cancer Immunology, Immunotherapy;2024-08-06

5. Combined Chemotherapy and Immunotherapy Induction for Screening of Patients with Cervical Esophageal Carcinoma for Subsequent Local Treatment: A New Treatment Paradigm;Annals of Surgical Oncology;2024-07-26